Get started
Biotechking

REGN projection to 750 analyst target

Long
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)  
Biotechking Updated   
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
Trend Analysis
4
0
trendanalysis
Used the pitch fork tool to determine when the current trend would align with the new analyst target of 750. First time using tool. Please provide feedback.
Comment:
Going to breakout or down. Earnings aug 5. I’ll beat up.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.